Page 7 - Jay Evans News Today

The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.

<p>Flu season is upon us, and existing vaccines are only ~40-60% effective at reducing the risk of serious illness. The <a href="https://www.childrenshospital.org/research/departments/pediatrics-research/precision-vaccines-program">Precision Vaccines Program</a> (PVP) at Boston Children’s Hospital was awarded a Vaccine Adjuvant Development Program contract (75N93023C00040) from the National Institutes of Health (NIH)/National Institute of Allergy an...

MISSOULA – The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for

MISSOULA – The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for

The National Institutes of Health awarded a $12.3 million contract to the University of motnana to develop a novel vaccine.The National Institutes of Health rec

Human trials are expected to start in early 2024 for both vaccines, according to UM.

/PRNewswire/ -- Inimmune, a leading biotech company focused on the development of novel vaccine adjuvants, immunotherapies and delivery systems, announced...

10 more people charged as police investigate murder of Matthew Daulby

Vaccines are in development that generate an antibody response against fentanyl and opioids rather than against a bacteria or virus.

A vaccine to prevent overdosing on fentanyl and one for heroin are in the works at the University of Montana and partner institutions.